All three candidate biomarker genes (PCA3: p = 0.002, S100A4: p ≤ 0.0001, and MRC2: p = 0.005) demonstrated statistically significant differences in expression between PC patients and healthy controls in plasma samples (see details in Supplementary Figure S1). The gene discussed is S100A4; the disease is pachyonychia congenita.